Allenet, C.; Klein, C.; Rouget, B.; Margue, G.; Capon, G.; Alezra, E.; Blanc, P.; Estrade, V.; Bladou, F.; Robert, G.;
et al. Can Pre-Operative Neutrophil-to-Lymphocyte Ratio (NLR) Help Predict Non-Metastatic Renal Carcinoma Recurrence after Nephrectomy? (UroCCR-61 Study). Cancers 2022, 14, 5692.
https://doi.org/10.3390/cancers14225692
AMA Style
Allenet C, Klein C, Rouget B, Margue G, Capon G, Alezra E, Blanc P, Estrade V, Bladou F, Robert G,
et al. Can Pre-Operative Neutrophil-to-Lymphocyte Ratio (NLR) Help Predict Non-Metastatic Renal Carcinoma Recurrence after Nephrectomy? (UroCCR-61 Study). Cancers. 2022; 14(22):5692.
https://doi.org/10.3390/cancers14225692
Chicago/Turabian Style
Allenet, Clément, Clément Klein, Benjamin Rouget, Gaëlle Margue, Grégoire Capon, Eric Alezra, Peggy Blanc, Vincent Estrade, Franck Bladou, Grégoire Robert,
and et al. 2022. "Can Pre-Operative Neutrophil-to-Lymphocyte Ratio (NLR) Help Predict Non-Metastatic Renal Carcinoma Recurrence after Nephrectomy? (UroCCR-61 Study)" Cancers 14, no. 22: 5692.
https://doi.org/10.3390/cancers14225692
APA Style
Allenet, C., Klein, C., Rouget, B., Margue, G., Capon, G., Alezra, E., Blanc, P., Estrade, V., Bladou, F., Robert, G., & Bernhard, J.-C.
(2022). Can Pre-Operative Neutrophil-to-Lymphocyte Ratio (NLR) Help Predict Non-Metastatic Renal Carcinoma Recurrence after Nephrectomy? (UroCCR-61 Study). Cancers, 14(22), 5692.
https://doi.org/10.3390/cancers14225692
